Abel Noser Solutions offers the industry's most comprehensive TCA analytics and transaction monitoring solutions for the institutional investment community. Our leading trade surveillance and compliance analytics can provide your clients with the critical transparency, substantive due diligence, and insight into how your managers are handling fund assets.
In fact, we've been extending access to our innovative TCA platform for years so our partner stakeholders can utilize our company’s unique transaction cost analytics solutions and trade surveillance offerings. Our leveraged efficiencies and streamlined processes - from on-boarding to delivery - can yield an ideal global, multi-asset TCA client experience that can be wholly integrated into third-party platforms. We can also assist partnership clients with addressing ongoing regulatory challenges by helping them remain compliant and competitive in today’s investment landscape.
Whether you are performing investment manager searches, generating periodic performance reports, providing third-party plan analysis or performing due diligence reports, we can provide you and your clients with tailor-made reporting, manager analytics and bespoke data feeds that support your client's investment objectives.
Not only can we provide customized metrics so excessive trade costs can be monitored, often the single largest expense of a fund or portfolio, we offer the compliance reporting and archiving necessary to mitigate regulatory, investment and fiduciary risk.
With decades of experience and leading-edge technology, Abel Noser offers customized best execution services, low commission rates and world-class client support.
There are a number of ways a company can work with us to experience our best-in-class products and services:
Please contact us at email@example.com to learn more.
Request a Free Demo Trial
Click below to learn how our powerful end-to-end trading and transaction surveillance platform can provide transparency and support your compliance mandates. We can set your clients up with a no-cost trial using their proprietary trade data ...